Le Lézard
Classified in: Environment, Science and technology
Subject: TDS

GENH2 Founder and CEO Cody Bateman to speak at World Hydrogen Congress, October 11-13, 2022 in Rotterdam


As Platinum Sponsor, the Hydrogen Infrastructure Leader Will Present Groundbreaking Storage and Liquefaction Solutions

TITUSVILLE, Fla., Oct. 6, 2022 /PRNewswire-PRWeb/ -- GenH2, a leader in hydrogen infrastructure technology, announced today that the company's Founder and CEO Cody Bateman will participate in two groundbreaking sessions at the World Hydrogen Congress being held October 11-13 in Rotterdam, Netherlands. GenH2 is also a platinum sponsor of the event.

The World Hydrogen Congress was conceived in 2018 to act as the senior executive networking congress for the clean hydrogen industry. It is produced by the World Hydrogen Leaders, the exclusive hydrogen executive membership community. The mission of the World Hydrogen Congress is to accelerate the global commercialization of clean hydrogen and to help connect the industry by providing an annual diary date for high-quality content and high-intensity networking.

Joining 2,000 attendees and 250 speakers from forty countries, Bateman, an outspoken advocate for the Hydrogen Economy, will speak twice on stage on Thursday, October 13th. First as part of a panel, alongside Andreas Frixen of Alstom Group and Berit Hinnemann of Maersk, at 11:50 am titled "Making the business case for zero-emission: air transport, shipping and mobility." The panel, which will be moderated by Claire Behar of Hy Stor Energy, will focus on:

Bateman will also present on stage at 2:30 pm, during which he will touch on state-of-the-art cryogenic liquid hydrogen storage, long-term industrial zero-loss solutions and the process of building large-scale liquefaction plants.

"I'm excited to have the opportunity to address international industry leaders at this elite conference where the hydrogen world comes to do business," said Bateman, who is widely recognized as a leader in the field of hydrogen infrastructure research and development. "As a leader in the hydrogen infrastructure space, GenH2 is uniquely positioned to move the hydrogen economy forward into the future."

For more information, please visit http://www.genh2hydrogen.com and http://www.CodyBateman.com.

About GenH2
GenH2 is an industry leader in hydrogen infrastructure solutions. The Titusville, Florida-headquartered technology company was founded by Cody Bateman, who is widely recognized as a visionary and expert in this industry. The GenH2 team includes former NASA researchers and developers who possess decades of experience researching, engineering, and producing hydrogen solutions. GenH2 is focused on the mass production of infrastructure equipment necessary for the transition to a clean energy economy. GenH2 technology will allow safe onsite production, storage, and distribution of liquid or gaseous hydrogen, making the product accessible for everyday use; the company has plans to deliver its product to hundreds of locations across the country in the coming years. Learn more about GenH2 at http://www.DiscoverHydrogen.com

Media Contact

Melissa Perlman, GenH2, 1 561-310-9921, [email protected]

 

SOURCE GenH2


These press releases may also interest you

at 21:30
Rubrik, Inc. today announced the pricing of its upsized initial public offering of 23,500,000 shares of its Class A common stock at a public offering price of $32.00 per share. In addition, Rubrik has granted the underwriters a 30-day option to...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:26
OKX, a leading Web3 technology company, has issued updates for April 24, 2024. OKX DeFi Launches 'zkSwap Bonus Event' Offering Users...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
The Board of Directors of TransAlta Corporation declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...



News published on and distributed by: